Lara Sullivan
2020
In 2020, Lara Sullivan earned a total compensation of $555K as Chief Executive Officer at Pyxis Oncology.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Salary | $375,000 |
| Total | $555,000 |
Sullivan received $375K in salary, accounting for 68% of the total pay in 2020.
Sullivan also received $180K in non-equity incentive plan.
Rankings
In 2020, Lara Sullivan's compensation ranked 10,727th out of 13,090 executives tracked by ExecPay. In other words, Sullivan earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,727 out of 13,090 | 18th |
Division Manufacturing | 4,585 out of 5,621 | 18th |
Major group Chemicals And Allied Products | 1,902 out of 2,254 | 16th |
Industry group Drugs | 1,667 out of 1,954 | 15th |
Industry Pharmaceutical Preparations | 1,230 out of 1,459 | 16th |
Source: SEC filing on April 28, 2022.